Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,626 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer.
Garnham R, Geh D, Nelson R, Ramon-Gil E, Wilson L, Schmidt EN, Walker L, Adamson B, Buskin A, Hepburn AC, Hodgson K, Kendall H, Frame FM, Maitland N, Coffey K, Strand DW, Robson CN, Elliott DJ, Heer R, Macauley M, Munkley J, Gaughan L, Leslie J, Scott E. Garnham R, et al. Among authors: scott e. Commun Biol. 2024 Mar 6;7(1):276. doi: 10.1038/s42003-024-05924-0. Commun Biol. 2024. PMID: 38448753 Free PMC article.
Glycans as Biomarkers in Prostate Cancer.
Scott E, Munkley J. Scott E, et al. Int J Mol Sci. 2019 Mar 19;20(6):1389. doi: 10.3390/ijms20061389. Int J Mol Sci. 2019. PMID: 30893936 Free PMC article. Review.
ST6GAL1: A key player in cancer.
Garnham R, Scott E, Livermore KE, Munkley J. Garnham R, et al. Among authors: scott e. Oncol Lett. 2019 Aug;18(2):983-989. doi: 10.3892/ol.2019.10458. Epub 2019 Jun 7. Oncol Lett. 2019. PMID: 31423157 Free PMC article. Review.
Androgen-regulated transcription of ESRP2 drives alternative splicing patterns in prostate cancer.
Munkley J, Li L, Krishnan SRG, Hysenaj G, Scott E, Dalgliesh C, Oo HZ, Maia TM, Cheung K, Ehrmann I, Livermore KE, Zielinska H, Thompson O, Knight B, McCullagh P, McGrath J, Crundwell M, Harries LW, Daugaard M, Cockell S, Barbosa-Morais NL, Oltean S, Elliott DJ. Munkley J, et al. Among authors: scott e. Elife. 2019 Sep 3;8:e47678. doi: 10.7554/eLife.47678. Elife. 2019. PMID: 31478829 Free PMC article.
Targeting Aberrant Sialylation to Treat Cancer.
Munkley J, Scott E. Munkley J, et al. Among authors: scott e. Medicines (Basel). 2019 Oct 13;6(4):102. doi: 10.3390/medicines6040102. Medicines (Basel). 2019. PMID: 31614918 Free PMC article.
FUT8 Alpha-(1,6)-Fucosyltransferase in Cancer.
Bastian K, Scott E, Elliott DJ, Munkley J. Bastian K, et al. Among authors: scott e. Int J Mol Sci. 2021 Jan 5;22(1):455. doi: 10.3390/ijms22010455. Int J Mol Sci. 2021. PMID: 33466384 Free PMC article. Review.
Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth.
Scott E, Hodgson K, Calle B, Turner H, Cheung K, Bermudez A, Marques FJG, Pye H, Yo EC, Islam K, Oo HZ, McClurg UL, Wilson L, Thomas H, Frame FM, Orozco-Moreno M, Bastian K, Arredondo HM, Roustan C, Gray MA, Kelly L, Tolson A, Mellor E, Hysenaj G, Goode EA, Garnham R, Duxfield A, Heavey S, Stopka-Farooqui U, Haider A, Freeman A, Singh S, Johnston EW, Punwani S, Knight B, McCullagh P, McGrath J, Crundwell M, Harries L, Bogdan D, Westaby D, Fowler G, Flohr P, Yuan W, Sharp A, de Bono J, Maitland NJ, Wisnovsky S, Bertozzi CR, Heer R, Guerrero RH, Daugaard M, Leivo J, Whitaker H, Pitteri S, Wang N, Elliott DJ, Schumann B, Munkley J. Scott E, et al. Oncogene. 2023 Mar;42(12):926-937. doi: 10.1038/s41388-023-02604-x. Epub 2023 Feb 1. Oncogene. 2023. PMID: 36725887 Free PMC article.
Engineering prostate cancer in vitro: what does it take?
Buskin A, Scott E, Nelson R, Gaughan L, Robson CN, Heer R, Hepburn AC. Buskin A, et al. Among authors: scott e. Oncogene. 2023 Aug;42(32):2417-2427. doi: 10.1038/s41388-023-02776-6. Epub 2023 Jul 12. Oncogene. 2023. PMID: 37438470 Free PMC article. Review.
2,626 results